InnoCore Pharmaceuticals
Alexander Vos serves on the Board of Directors for RoslinCT and Teknova Inc. and holds the position of Chairman of the Board at InnoCore Pharmaceuticals. Vos is a Venture Partner at BioGeneration Ventures, Managing Director at Biotech Mountains BV, and a member of the Supervisory Board at CiMaas BV. Previously, Vos served as CEO of VectorY Therapeutics and VarmX, as well as Chairman of the Board at Symeres and a Board member for the Alliance for Regenerative Medicine. Educational credentials include an MBA from Stanford University and a Master's degree in Pharmacy/Pharmacology from the University of Amsterdam. Additionally, Vos is currently enrolled in the Director’s Consortium program at Stanford University Graduate School of Business.
This person is not in the org chart
This person is not in any teams
InnoCore Pharmaceuticals
InnoCore specializes in the formulation, process development, and manufacturing of long acting and minimally invasive injectable drug delivery products. InnoCore offers a unique and highly tunable polymer platform to control the delivery drug compounds, including small molecules (e.g. peptides and low solubles) and biologics (e.g. proteins and antibodies). Our proprietary polymer platform features a variety of benefits to your API's such as: - solving toxicity challenges - maintaining/increasing stability and structural integrity of sensitive compounds (e.g. by applying low temperature process conditions during manufacturing) - sustained release of of drug molecules from days up to at least 6 months - precise control over particle size (preventing absorption by macrophages and ensuring injectability) - ensuring smooth bioavailability - enabling the use of small needle sizes for patient compliance By merging developmental collaborations and licensing partnerships with our exclusive SynBiosys biodegradable polymer technologies, we generate innovative injectable and implantable drug delivery products. We invite you to navigate through our website and discover how we can enhance the performance of your device and/or drug and add value to your product pipeline.